Gene expression profiling-based in silico approach to identify potential vaccine candidates and drug targets against B. pertussis and B. parapertussis

OMICS A Journal of Integrative Biology

Volumn 12, Issue 3, 2008, Pages 161-169

  Zhu, Yong Zhang ^a   Li, Qing Tian ^a   Wang, Li ^b   Zhong, Yi ^a   Ding, Guo Hui ^b   Li, Guang ^b   Jia, Pei Ling ^b   Shi, Tie Liu ^b   Guo, Xiao Kui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; COMPUTER MODEL; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; GENE FUSION; GENE IDENTIFICATION; GENOME; HUMAN; MICROARRAY ANALYSIS; PERTUSSIS; PRIORITY JOURNAL; VACCINATION;

ANIMALS; BACTERIAL PROTEINS; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; DRUG DESIGN; GENE EXPRESSION PROFILING; HUMANS; INFANT; MICROARRAY ANALYSIS; PERTUSSIS VACCINE; PROTEIN INTERACTION MAPPING;

BORDETELLA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS;

EID: 51349166201     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2008.0029     Document Type: Article

References (60)

1. Allsop, A., Brooks, G., Edwards, P.D., Kaura, A.C., and Southgate, R. (1996). Inhibitors of bacterial signal peptidase: a series of 6-(substituted oxyethyl)penems. J Antibiot (Tokyo) 49, 921-928.
2. Batada, N.N., Hurst, L.D., and Tyers, M. (2006). Evolutionary and physiological importance of hub proteins. PLoS Comput Biol 2, e88.
3. Bendtsen, J.D., Nielsen, H., Von Heijne, G., and Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340, 783-795.
4. Bergfors, E., Trollfors, B., Taranger, J., Lagergard, T., SUNDH, V., and Zackrisson, G. (1999). Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int J Infect Dis 3, 140-146.
5. Bhasin, M., Garg, A., and Raghava, G.P. (2005). PSLpred: prediction of subcellular localization of bacterial proteins. Bioinformatics 21, 2522-2524.
6. Brinig, M.M., Cummings, C.A., Sanden, G.N., Stefanelli, P., Lawrence, A., and Relman, D.A. (2006a). Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 188, 2375-2382.
7. Brinig, M.M., Register, K.B., Ackermann, M.R., and Relman, D.A. (2006b). Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol 7, R81.
8. Cummings, C.A., Bootsma, H.J., Relman, D.A., and Miller, J.F. (2006). Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 188, 1775-1785.
9. David, S., Van Furth, R., and Mooi, F.R. (2004). Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine 22, 1892-1898.
10. Gamberini, M., Gomez, R.M., Atzingen, M.V., Martins, E.A., Vasconcellos, S.A., Romero, E.C., et al. (2005). Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett 244, 305-313.
11. Gardy, J.L., and Brinkman, F.S. (2006). Methods for predicting bacterial protein subcellular localization. Nat Rev Microbiol 4, 741-751.
12. Gardy, J.L., Laird, M.R., Chen, F., Rey, S., Walsh, C.J., Ester, M., and Brinkman, F.S. (2005). PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21, 617-623.
13. Geuijen, C.A., Willems, R.J., and Mooi, F.R. (1996). The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars. Infect Immun 64, 2657-2665.
14. Gil, R., Silva, F.J., Pereto, J., and Moya, A. (2004). Determination of the core of a minimal bacterial gene set. Microbiol Mol Biol Rev 68, 518-537.
15. Grandi, G. (2004). Genomics, Proteomics and Vaccines. (John Wiley & Sons Ltd, Chichester).
16. Grifantini, R., Bartolini, E., Muzzi, A., Draghi, M., Frigimelica, E., Berger, J., et al. (2002). Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol 20, 914-921.
17. Gustafsson, L., Hallander, H.O., Olin, P., Reizenstein, E., and Storsaeter, J. (1996). A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334, 349-355.
18. Hazenbos, W.L., Van Den Berg, B.M., Geuijen, C.W., Mooi, F.R., and Van Furth, R. (1995). Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J Immunol 155, 3972-3978.
19. He, X., and Zhang, J. (2006). Why do hubs tend to be essential in protein networks? PLoS Genet 2, e88.
20. Heininger, U., Stehr, K., and Cherry, J.D. (1998). The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model. Vaccine 16, 1255.
21. Heininger, U., Stehr, K., Christenson, P., and Cherry, J.D. (1999). Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin Infect Dis 28, 602-604.
22. Hua, S., and Sun, Z. (2001). Support vector machine approach for protein subcellular localization prediction. Bioinformatics 17, 721-728.
23. Isaacson, R.E. (2002). Genomics and the prospects for the discovery of new targets for antibacterial and antifungal agents. Curr Pharm Des 8, 1091-1098.
24. Kall, L., Krogh, A., and Sonnhammer, E.L. (2004). A combined transmembrane topology and signal peptide prediction method. J Mol Biol 338, 1027-1036.
25. Krogh, A., Larsson, B., Von Heijne, G., and Sonnhammer, E.L. (2001). Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305, 567-580.
26. Liese, J.G., Renner, C., Stojanov, S., and Belohradsky, B.H. (2003). Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child 88, 684-687.
27. Locht, C. (1999). Molecular aspects of Bordetella pertussis pathogenesis. Int Microbiol 2, 137-144.
28. MacDonald-Fyall, J., Xing, D., Corbel, M., Baillie, S., Parton, R., and Coote, J. (2004). Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Vaccine 22, 4270-4281.
29. Marcotte, E.M., Pellegrini, M., Ng, H.L., Rice, D.W., Yeates, T.O., and Eisenberg, D. (1999). Detecting protein function and protein-protein interactions from genome sequences. Science 285, 751-753.
30. Mattoo, S., and Cherry, J.D. (2005). Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18, 326-382.
31. Mazar, J., and Cotter, P.A. (2006). Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion. Mol Microbiol 62, 641-654.
32. Mielcarek, N., Debrie, A.S., Raze, D., Bertout, J., Rouanet, C., Younes, A.B., et al. (2006). Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2, e65.
33. Nair, R., and Rost, B. (2005). Mimicking cellular sorting improves prediction of subcellular localization. J Mol Biol 348, 85-100.
34. Overbeek, R., Fonstein, M., D'Souza, M., Pusch, G.D., and Maltsev, N. (1999). The use of gene clusters to infer functional coupling. Proc Natl Acad Sci USA 96, 2896-2901.
35. Parkhill, J., Sebaihia, M., Preston, A., Murphy, L.D., Thomson, N., Harris, D.E., and et al. (2003). Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35, 32-40.
36. Pellegrini, M., Marcotte, E.M., Thompson, M.J., Eisenberg, D., and Yeates, T.O. (1999). Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. Proc Natl Acad Sci USA 96, 4285-4288.
37. Perez Vidakovics, M.L., Lamberti, Y., Van Der Pol, W.L., Yantorno, O., and Rodriguez, M.E. (2006). Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells. FEMS Immunol Med Microbiol 48, 140-147.
38. Pizza, M., Scarlato, V., Masignani, V., Giuliani, M.M., Arico, B., Comanducci, M., et al. (2000). Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816-1820.
39. Preston, A., Parkhill, J., and Maskell, D.J. (2004). The bordetellae: lessons from genomics. Nat Rev Microbiol 2, 379-390.
40. Roemer, T., Jiang, B., Davison, J., Ketela, T., Veillette, K., Breton, A., et al. (2003). Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 50, 167-181.
41. Ross, B.C., Czajkowski, L., Hocking, D., Margetts, M., Webb, E., Rothel, et al. (2001). Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 19, 4135-4142.
42. Sato, Y., Kimura, M., and Fukumi, H. (1984). Development of a pertussis component vaccine in Japan. Lancet 1, 122-126.
43. Serruto, D., Adu-Bobie, J., Capecchi, B., Rappuoli, R., Pizza, M., and Masignani, V. (2004). Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. J Biotechnol 113, 15-32.
44. Song, J.H., Ko, K.S., Lee, J.Y., Baek, J.Y., Oh, W.S., Yoon, H.S., et al. (2005). Identification of essential genes in Streptococcus pneumoniae by allelic replacement mutagenesis. Mol Cells 19, 365-374.
45. Strong, M., and Eisenberg, D. (2007). The protein network as a tool for finding novel drug targets. Prog Drug Res 191, 193-215.
46. Strong, M., Mallick, P., Pellegrini, M., Thompson, M.J., and Eisenberg, D. (2003). Inference of protein function and protein linkages in Mycobacterium tuberculosis based on prokaryotic genome organization: a combined computational approach. Genome Biol 4, R59.
47. Sun, J., Zheng, L., Landwehr, C., Yang, J., and Ji, Y. (2005). Identification of a novel essential two-component signal transduction system, YhcSR, in Staphylococcus aureus. J Bacteriol 187, 7876-7880.
48. Sun, J., Sun, Y., Ding, G., Liu, Q., Wang, C., He, Y., Shi, T., et al. (2007). InPrePPI: an integrated evaluation method based on genomic context for predicting protein-protein interactions in prokaryotic genomes. BMC Bioinformatics 8, 414.
49. Szafron, D., Lu, P., Greiner, R., Wishart, D.S., Poulin, B., Eisner, R., et al. (2004). Proteome analyst: custom predictions with explanations in a web-based tool for high-throughput proteome annotations. Nucleic Acids Res 32, W365-W371.
50. Thanassi, J.A., Hartman-Neumann, S.L., Dougherty, T.J., Dougherty, B.A., and Pucci, M.J. (2002). Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. Nucleic Acids Res 30, 3152-3162.
51. Tiwari, T., Murphy, T.V., and Moran, J. (2005). Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 54, 1-16.
52. Van Den Akker, W.M. (1998). The filamentous hemagglutinin of Bordetella parapertussis is the major adhesin in the phase-dependent interaction with NCI-H292 human lung epithelial cells. Biochem Biophys Res Commun 252, 128-133.
53. Wang, J., Sung, W.K., Krishnan, A., and Li, K.B. (2005). Protein subcellular localization prediction for Gram-negative bacteria using amino acid subalphabets and a combination of multiple support vector machines. BMC Bioinformatics 6, 174.
54. Watanabe, M., and Nagai, M. (2001). Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun 69, 6981-6986.
55. Watanabe, M., and Nagai, M. (2004). Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2, 447-454.
56. World Health Organization [WHO]. (2004). The world health report 2004 - changing history. Available: http://www.who.int/whr/2004/en. Accessed 31 May 2006.
57. Willems, R.J., Kamerbeek, J., Geuijen, C.A., Top, J., Gielen, H., Gaastra, W., et al. (1998). The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine 16, 410-416.
58. Yang, H.L., Zhu, Y.Z., Qin, J.H., He, P., Jiang, X.C., Zhao, G.P., et al. (2006). In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. BMC Genomics 7, 293.
59. Yu, C.S., Lin, C.J., and Hwang, J.K. (2004a). Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci 13, 1402-1406.
60. Yu, H., Greenbaum, D., Xin Lu, H., Zhu, X., and Gerstein, M. (2004b). Genomic analysis of essentiality within protein networks. Trends Genet 20, 227-231.